CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 17 enrolled
Drug / intervention
Octanoic acid +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01864525
NCT01864525Phase 2Completed

Effects of Octanoic Acid for Treatment of Essential Voice Tremor

Syracuse University·interventional·Posted May 29, 2013·Updated Aug 20, 2018

In Brief

A Phase 2 clinical trial evaluating Octanoic acid and Inactive capsule for Essential Voice Tremor and 3 related conditions. Completed, enrolled 17 participants across 1 site.

Detailed Summary

Essential voice tremor is a neurological condition that produces a regular, shaking quality in the voice. One form of drug treatment that produces some improvement in tremor of the hands is octanoic acid, which is a food additive that is similar to alcohol. Research suggests that octanoic acid may reduce tremor in the hands/arms with few side effects and no intoxication effects. This study will determine whether octanoic acid may be useful for reducing tremor when it affects the voice. Researchers are hypothesizing that octanoic acid will reduce the effects of tremor on the voice.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedMay 29, 2013
Enrollment StartJul 1, 2013
Primary CompletionDec 22, 2016
Study CompletionMar 31, 2017
TodayJul 2, 2026
Enrollment to primary: 3.5 yearsPosted 13.1 years ago

Interventions

Octanoic aciddrug

Inactive capsuledrug